ZACHARY FLACCAVENTO: Open Payments
NPI 1851975577 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$756 in 36 payments from 15 companies in 2025. Trend: 2023 $767 · 2024 $603 · 2025 $756
Food & beverage: $756
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 9 | $168 |
| Amgen Inc. | 4 | $87 |
| Novo Nordisk Inc | 3 | $61 |
| Calliditas Therapeutics US Inc. | 2 | $60 |
| Mallinckrodt Hospital Products Inc. | 3 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $54 |
| Fresenius USA Marketing, Inc. | 2 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| KYOWA KIRIN, INC. | 1 | $24 |
Products named: IBSRELA, JARDIANCE, KRYSTEXXA, TARPEYO, JYNARQUE, VELPHORO, Kerendia, TERLIVAZ.
Industry payments across NC — which companies pay providers there.
